CATHERINE ELLIS: Open Payments
NPI 1487056974 · ALEXANDRIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 78 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $447 · 2025 $1,760
Food & beverage: $1,754Travel & lodging: $6
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $244 |
| AstraZeneca Pharmaceuticals LP | 3 | $223 |
| Edwards Lifesciences Corporation | 2 | $209 |
| Axsome Therapeutics, Inc. | 10 | $205 |
| Lilly USA, LLC | 10 | $174 |
| Novo Nordisk Inc | 10 | $168 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $81 |
| PFIZER INC. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
Products named: AIRSUPRA, SAPIEN 3 Ultra RESILIA, Auvelity, QULIPTA, JARDIANCE, VRAYLAR, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across KY — which companies pay providers there.
